Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2004 Jul;89(7):648–652. doi: 10.1136/adc.2003.029942

Fatty liver disease in children

A Marion 1, A Baker 1, A Dhawan 1
PMCID: PMC1719985  PMID: 15210498

Full Text

The Full Text of this article is available as a PDF (141.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen T., Gluud C., Franzmann M. B., Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol. 1991 Mar;12(2):224–229. doi: 10.1016/0168-8278(91)90942-5. [DOI] [PubMed] [Google Scholar]
  2. Angulo P., Keach J. C., Batts K. P., Lindor K. D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999 Dec;30(6):1356–1362. doi: 10.1002/hep.510300604. [DOI] [PubMed] [Google Scholar]
  3. Bacon B. R., Farahvash M. J., Janney C. G., Neuschwander-Tetri B. A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 1994 Oct;107(4):1103–1109. doi: 10.1016/0016-5085(94)90235-6. [DOI] [PubMed] [Google Scholar]
  4. Baldridge A. D., Perez-Atayde A. R., Graeme-Cook F., Higgins L., Lavine J. E. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr. 1995 Nov;127(5):700–704. doi: 10.1016/s0022-3476(95)70156-7. [DOI] [PubMed] [Google Scholar]
  5. Basaranoglu M., Acbay O., Sonsuz A. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatol. 1999 Aug;31(2):384–384. doi: 10.1016/s0168-8278(99)80243-8. [DOI] [PubMed] [Google Scholar]
  6. Burt A. D., Mutton A., Day C. P. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol. 1998 Nov;15(4):246–258. [PubMed] [Google Scholar]
  7. Caldwell S. H., Hespenheide E. E., Redick J. A., Iezzoni J. C., Battle E. H., Sheppard B. L. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol. 2001 Feb;96(2):519–525. doi: 10.1111/j.1572-0241.2001.03553.x. [DOI] [PubMed] [Google Scholar]
  8. Caldwell S. H., Oelsner D. H., Iezzoni J. C., Hespenheide E. E., Battle E. H., Driscoll C. J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999 Mar;29(3):664–669. doi: 10.1002/hep.510290347. [DOI] [PubMed] [Google Scholar]
  9. Charlton M., Kasparova P., Weston S., Lindor K., Maor-Kendler Y., Wiesner R. H., Rosen C. B., Batts K. P. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl. 2001 Jul;7(7):608–614. doi: 10.1053/jlts.2001.25453. [DOI] [PubMed] [Google Scholar]
  10. Crespo J., Cayón A., Fernández-Gil P., Hernández-Guerra M., Mayorga M., Domínguez-Díez A., Fernández-Escalante J. C., Pons-Romero F. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology. 2001 Dec;34(6):1158–1163. doi: 10.1053/jhep.2001.29628. [DOI] [PubMed] [Google Scholar]
  11. Day C. P., James O. F. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998 Apr;114(4):842–845. doi: 10.1016/s0016-5085(98)70599-2. [DOI] [PubMed] [Google Scholar]
  12. Day C. P. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002 Oct;16(5):663–678. doi: 10.1053/bega.2002.0333. [DOI] [PubMed] [Google Scholar]
  13. Drenick E. J., Fisler J., Johnson D. Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology. 1982 Mar;82(3):535–548. [PubMed] [Google Scholar]
  14. Hasegawa T., Yoneda M., Nakamura K., Makino I., Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther. 2001 Oct;15(10):1667–1672. doi: 10.1046/j.1365-2036.2001.01083.x. [DOI] [PubMed] [Google Scholar]
  15. James O. F., Day C. P. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol. 1998 Sep;29(3):495–501. doi: 10.1016/s0168-8278(98)80073-1. [DOI] [PubMed] [Google Scholar]
  16. Kinugasa A., Tsunamoto K., Furukawa N., Sawada T., Kusunoki T., Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr. 1984 Jun;3(3):408–414. doi: 10.1097/00005176-198406000-00018. [DOI] [PubMed] [Google Scholar]
  17. Laurin J., Lindor K. D., Crippin J. S., Gossard A., Gores G. J., Ludwig J., Rakela J., McGill D. B. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology. 1996 Jun;23(6):1464–1467. doi: 10.1002/hep.510230624. [DOI] [PubMed] [Google Scholar]
  18. Lavine J. E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr. 2000 Jun;136(6):734–738. [PubMed] [Google Scholar]
  19. Ludwig J., Viggiano T. R., McGill D. B., Oh B. J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980 Jul;55(7):434–438. [PubMed] [Google Scholar]
  20. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., McCullough A. J., Natale S., Forlani G., Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001 Aug;50(8):1844–1850. doi: 10.2337/diabetes.50.8.1844. [DOI] [PubMed] [Google Scholar]
  21. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Zoli M., Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet. 2001 Sep 15;358(9285):893–894. doi: 10.1016/s0140-6736(01)06042-1. [DOI] [PubMed] [Google Scholar]
  22. Matteoni C. A., Younossi Z. M., Gramlich T., Boparai N., Liu Y. C., McCullough A. J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999 Jun;116(6):1413–1419. doi: 10.1016/s0016-5085(99)70506-8. [DOI] [PubMed] [Google Scholar]
  23. Molleston Jean P., White Frances, Teckman Jeffrey, Fitzgerald Joseph F. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol. 2002 Sep;97(9):2460–2462. doi: 10.1111/j.1572-0241.2002.06003.x. [DOI] [PubMed] [Google Scholar]
  24. Moran J. R., Ghishan F. K., Halter S. A., Greene H. L. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol. 1983 Jun;78(6):374–377. [PubMed] [Google Scholar]
  25. Palmer M., Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990 Nov;99(5):1408–1413. doi: 10.1016/0016-5085(90)91169-7. [DOI] [PubMed] [Google Scholar]
  26. Pappo I., Becovier H., Berry E. M., Freund H. R. Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat. J Surg Res. 1991 Aug;51(2):106–112. doi: 10.1016/0022-4804(91)90078-z. [DOI] [PubMed] [Google Scholar]
  27. Pessayre D., Berson A., Fromenty B., Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis. 2001;21(1):57–69. doi: 10.1055/s-2001-12929. [DOI] [PubMed] [Google Scholar]
  28. Powell E. E., Cooksley W. G., Hanson R., Searle J., Halliday J. W., Powell L. W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990 Jan;11(1):74–80. doi: 10.1002/hep.1840110114. [DOI] [PubMed] [Google Scholar]
  29. Rashid M., Roberts E. A. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000 Jan;30(1):48–53. doi: 10.1097/00005176-200001000-00017. [DOI] [PubMed] [Google Scholar]
  30. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., Khalil L., Turpin G., Opolon P., Poynard T. Liver fibrosis in overweight patients. Gastroenterology. 2000 Jun;118(6):1117–1123. doi: 10.1016/s0016-5085(00)70364-7. [DOI] [PubMed] [Google Scholar]
  31. Sanyal A. J., Campbell-Sargent C., Mirshahi F., Rizzo W. B., Contos M. J., Sterling R. K., Luketic V. A., Shiffman M. L., Clore J. N. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001 Apr;120(5):1183–1192. doi: 10.1053/gast.2001.23256. [DOI] [PubMed] [Google Scholar]
  32. Saxena Neeraj K., Ikeda Kazuo, Rockey Don C., Friedman Scott L., Anania Frank A. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology. 2002 Apr;35(4):762–771. doi: 10.1053/jhep.2002.32029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shimada Masahiko, Hashimoto Etsuko, Taniai Makiko, Hasegawa Kiyoshi, Okuda Hiroaki, Hayashi Naoaki, Takasaki Ken, Ludwig Jurgen. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2002 Jul;37(1):154–160. doi: 10.1016/s0168-8278(02)00099-5. [DOI] [PubMed] [Google Scholar]
  34. Struben V. M., Hespenheide E. E., Caldwell S. H. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med. 2000 Jan;108(1):9–13. doi: 10.1016/s0002-9343(99)00315-0. [DOI] [PubMed] [Google Scholar]
  35. Tazawa Y., Noguchi H., Nishinomiya F., Takada G. Serum alanine aminotransferase activity in obese children. Acta Paediatr. 1997 Mar;86(3):238–241. doi: 10.1111/j.1651-2227.1997.tb08881.x. [DOI] [PubMed] [Google Scholar]
  36. Teli M. R., James O. F., Burt A. D., Bennett M. K., Day C. P. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995 Dec;22(6):1714–1719. [PubMed] [Google Scholar]
  37. Tominaga K., Kurata J. H., Chen Y. K., Fujimoto E., Miyagawa S., Abe I., Kusano Y. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci. 1995 Sep;40(9):2002–2009. doi: 10.1007/BF02208670. [DOI] [PubMed] [Google Scholar]
  38. Vajro P., Fontanella A., Perna C., Orso G., Tedesco M., De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr. 1994 Aug;125(2):239–241. doi: 10.1016/s0022-3476(94)70202-0. [DOI] [PubMed] [Google Scholar]
  39. Wanless I. R., Lentz J. S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990 Nov;12(5):1106–1110. doi: 10.1002/hep.1840120505. [DOI] [PubMed] [Google Scholar]
  40. Willner I. R., Waters B., Patil S. R., Reuben A., Morelli J., Riely C. A. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol. 2001 Oct;96(10):2957–2961. doi: 10.1111/j.1572-0241.2001.04667.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES